Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Penack, Olaf, Becker, Carolin, Buchheidt, Dieter, Christopeit, Maximilian, Kiehl, Michael, von Lilienfeld-Toal, Marie, Hentrich, Marcus, Reinwald, Marc, Salwender, Hans, Schalk, Enrico, Schmidt-Hieber, Martin, Weber, Thomas, Ostermann, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050292/
https://www.ncbi.nlm.nih.gov/pubmed/24777705
http://dx.doi.org/10.1007/s00277-014-2086-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050292/
https://www.ncbi.nlm.nih.gov/pubmed/24777705
http://dx.doi.org/10.1007/s00277-014-2086-0

Ejemplares similares